Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

[Full Text]
Displaying Investigations 1 to 74 of 74 found
From 10 References


Frattini et al 2013, Nat Genet
  Astrocytoma, grade III-IV/Glioblastoma Brain
SNTB2/VPS4A
t(16;16)(q22;q22)

Hu et al 2018, Nucleic Acids Res
  Adenocarcinoma Liver
AP1G1/PMFBP1
t(16;16)(q22;q22)
  Mesenchymal tumor, NOS Unknown site
AP1G1/MTSS1L
t(16;16)(q22;q22)
  Adenocarcinoma Oesophagus
CBFB/NAE1
t(16;16)(q22;q22)
  Astrocytoma, grade I-II Brain
CBFB/COG4
t(16;16)(q22;q22)
  Adenocarcinoma Uterus, corpus
CBFB/CA7
t(16;16)(q22;q22)
  Adenocarcinoma Oesophagus
CDH3/C16orf70
t(16;16)(q22;q22)
  Adenocarcinoma Liver
CES4A/PDP2
t(16;16)(q22;q22)
  Adenocarcinoma Stomach
CMTM4/CMTM3
t(16;16)(q22;q22)
  Squamous cell carcinoma Uterus, cervix
CMTM4/DYNC1LI2
t(16;16)(q22;q22)
  Mesenchymal tumor, NOS Unknown site
COG4/PMFBP1
t(16;16)(q22;q22)
  Adenocarcinoma Uterus, corpus
COG4/VAC14
t(16;16)(q22;q22)
  Adenocarcinoma Stomach
CTCF/HSD11B2
t(16;16)(q22;q22)
  Squamous cell carcinoma Lung
CTCF/E2F4
t(16;16)(q22;q22)
  Squamous cell carcinoma Unknown site
CTCF/GFOD2
t(16;16)(q22;q22)
  Adenocarcinoma Liver
DDX19B/ST3GAL2
t(16;16)(q22;q22)
  Adenocarcinoma Oesophagus
DYNC1LI2/NAE1
t(16;16)(q22;q22)
  Adenocarcinoma Stomach
FUK/PDPR
t(16;16)(q22;q22)
  Squamous cell carcinoma Lung
NFAT5/CDH3
t(16;16)(q22;q22)
  Squamous cell carcinoma Lung
NFAT5/NOB1
t(16;16)(q22;q22)
  Transitional cell carcinoma Bladder
NFAT5/CHST4
t(16;16)(q22;q22)
  Adenocarcinoma Large intestine
NFAT5/VPS4A
t(16;16)(q22;q22)
  Adenocarcinoma Liver
NFAT5/SLC7A6
t(16;16)(q22;q22)
  Adenocarcinoma Adrenal
NUTF2/TSNAXIP1
t(16;16)(q22;q22)
  Squamous cell carcinoma Uterus, cervix
PSKH1/TSNAXIP1
t(16;16)(q22;q22)
  Adenocarcinoma Liver
RANBP10/LCAT
t(16;16)(q22;q22)
  Adenocarcinoma Adrenal
SLC12A4/DPEP2
t(16;16)(q22;q22)
  Adenocarcinoma Uterus, corpus
SLC7A6/PLA2G15
t(16;16)(q22;q22)
  Malignant epithelial tumor, special type Uterus, corpus
SLC7A6/C16orf70
t(16;16)(q22;q22)
  Adenocarcinoma Lung
VAC14/HYDIN
t(16;16)(q22;q22)
  Adenocarcinoma Lung
WWP2/CYB5B
t(16;16)(q22;q22)
  Adenocarcinoma Stomach
WWP2/NFAT5
t(16;16)(q22;q22)
  Squamous cell carcinoma Uterus, cervix
ZFHX3/IL34
t(16;16)(q22;q22)
  Adenocarcinoma Prostate
ZFHX3/C16orf47
t(16;16)(q22;q22)
  Squamous cell carcinoma Lung
ZFHX3/WWP2
t(16;16)(q22;q22)
  Adenocarcinoma Prostate
ZFHX3/ZNF821
t(16;16)(q22;q22)

Morin et al 2013, Blood
  Diffuse large B-cell lymphoma
CENPT/NUTF2
t(16;16)(q22;q22)
B-Lineage

Natrajan et al 2014, J Pathol
  Adenocarcinoma Breast
CYB5B/CALB2
t(16;16)(q22;q22)

Pintarelli et al 2016, Oncotarget
  Nonneoplastic epithelial disorder/lesion Lung
AGRP/ATP6V0D1
t(16;16)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Lung
NFATC3/PLA2G15
t(16;16)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Lung
SNTB2/VPS4A
t(16;16)(q22;q22)
  Nonneoplastic epithelial disorder/lesion Lung
ZDHHC1/TPPP3
t(16;16)(q22;q22)

Seki et al 2017, Nat Genet
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
CTCF/SLC7A6
t(16;16)(q22;q22)
T-Lineage

Seshagiri et al 2012, Nature
  Adenocarcinoma Large intestine
COG8/TERF2
t(16;16)(q22;q22)

Wen et al 2012, PLoS One
  Acute myeloid leukemia, NOS
NFATC3/PLA2G15
t(16;16)(q22;q22)

Yoshihara et al 2015, Oncogene
  Malignant melanoma Skin
CTCF/CES2
t(16;16)(q22;q22)
  Malignant melanoma Skin
TANGO6/CDH1
t(16;16)(q22;q22)
  Malignant melanoma Skin
ATP6V0D1/DUS2
t(16;16)(q22;q22)
  Malignant melanoma Skin
DUS2/HSD11B2
t(16;16)(q22;q22)
  Adenocarcinoma Ovary
ST3GAL2/COG4
t(16;16)(q22;q22)
  Adenocarcinoma Ovary
WWP2/TANGO6
t(16;16)(q22;q22)
  Squamous cell carcinoma Lung
MTSS1L/VAC14
t(16;16)(q22;q22)
  Adenocarcinoma Lung
NFAT5/FHOD1
t(16;16)(q22;q22)
  Adenocarcinoma Lung
FAM65A/LRRC36
t(16;16)(q22;q22)
  Adenocarcinoma Lung
SLC7A6/NFATC3
t(16;16)(q22;q22)
  Adenocarcinoma Lung
RANBP10/SLC12A4
t(16;16)(q22;q22)
  Adenocarcinoma Lung
RANBP10/SLC7A6
t(16;16)(q22;q22)
  Adenocarcinoma Lung
DUS2/RLTPR
t(16;16)(q22;q22)
  Adenocarcinoma Lung
IL34/ST3GAL2
t(16;16)(q22;q22)
  Adenocarcinoma Lung
SNTB2/CIRH1A
t(16;16)(q22;q22)
  Adenocarcinoma Kidney
DDX19B/KCTD19
t(16;16)(q22;q22)
  Adenocarcinoma Kidney
DDX19A/CIRH1A
t(16;16)(q22;q22)
  Squamous cell carcinoma Oral cavity
SNTB2/TANGO6
t(16;16)(q22;q22)
  Squamous cell carcinoma Oral cavity
CBFB/CES4A
t(16;16)(q22;q22)
  Astrocytoma, grade III-IV/Glioblastoma Brain
SF3B3/DDX19B
t(16;16)(q22;q22)
  Adenocarcinoma Breast
PRMT7/NFATC3
t(16;16)(q22;q22)
  Adenocarcinoma Breast
TERF2/COG4
t(16;16)(q22;q22)
  Adenocarcinoma Breast
AARS/ST3GAL2
t(16;16)(q22;q22)
  Adenocarcinoma Breast
AARS/COG4
t(16;16)(q22;q22)
  Adenocarcinoma Breast
SF3B3/COG4
t(16;16)(q22;q22)
  Adenocarcinoma Breast
LRRC29/FHOD1
t(16;16)(q22;q22)
  Adenocarcinoma Breast
SNTB2/CHST4
t(16;16)(q22;q22)
  Adenocarcinoma Breast
ESRP2/SLC7A6
t(16;16)(q22;q22)

Zheng et al 2016, Cancer Cell
  Adenocarcinoma Adrenal
CYB5B/TERF2
t(16;16)(q22;q22)